| WARF: P00385US |  |
| Treatment Of T-cell Immunodeficiencies With Vitamin D Compounds |
| INVENTORS | • | Hector DeLuca, Shouli Yang, Jean Prahl, Connie Smith |
OVERVIEW
A method for treating a T-cell immunodeficiency in a mammal by administering an amount of a vitamin D compound, such as vitamin D3, its active form 1 alpha,25-dihydroxyvitamin D3 or other compounds exhibiting vitamin D-like activity, to the mammal for a sufficient period of time to improve or restore the immunity of the mammal.
ADDITIONAL INFORMATION
Intellectual Property Status
Tech Fields
Pharmaceuticals & Vitamin D - Vitamin D
CONTACT INFORMATION
For current licensing status, please contact our team at
licensing@warf.org
or phone 608.262.4924. (Clicking this link will open a contact form in a popup window. If you have problems viewing the form, try disabling your popup blocker software.)
Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.
